News

Suzanne Kincaid to Present on Risk Management at MAGI’s Clinical Research East

Suzanne Kincaid to Present on Risk Management at MAGI Clinical Research East 2022

APRIL 26, 2022

Aperio’s Suzanne Kincaid will facilitate a panel presentation on risk based quality management on Tuesday, May 3rd at 10:45 am EDT at MAGI’s Clinical Research Conference East in Boston.

During the session, Suzanne and her esteemed panelists – Maryse Brulotte from the University of Utah and Judyth Zahora from Agenus – will discuss how to Assess, Characterize, and Manage Risk in Clinical Research.

Register today to attend  MAGI’s Clinical Research Conference East and learn how to reap the benefits of a risk-based approach on your next clinical trial.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Aperio Poised for Strategic Growth Appoints Eric Ross as Vice President of Business Development

Aperio Poised for Strategic Growth;
Appoints Eric Ross as Vice President of Business Development

NOVEMBER 9, 2021

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aperio Clinical Outcomes, a leading clinical research organization (CRO), announced that Eric Ross has joined the company as Vice President of Business Development to drive new growth and strengthen existing client relationships.

Ross has over 16 years of experience in life sciences, including eight years leading Business Development growth for the CRO industry at MedSource, Chiltern and Ockham Oncology. Prior to this, he served in various Director and Manager Operations roles at Almac and etrials Worldwide where he held senior operations positions in Project Management, Product Management and Global Support Services. Mr. Ross’ experience across various segments of the clinical trial industry allows him to be uniquely attuned to the challenges Aperio’s small and mid-size biotech clients face.

According to Aperio’s Founder and CEO Faye Woolf, “Eric’s appointment comes at a crucial time in the industry. With the rise in complex protocol designs and the growing volume and number of data sources, clinical trials risks have never been greater. These risks are especially palpable for our small and emerging biotech customers. Aperio wants to strengthen our partnerships with the biotech community and educate them on how a data-driven, risk-based approach can help them manage trial risks, increase the overall quality of their clinical development programs, and often save them time and money. Eric’s strong principles, coupled with his operations background and Business Development acumen, will enable Eric to position Aperio to grow strategically in a way that allows Aperio to excel while simultaneously providing the solutions our small- and mid-size biotech customers need.”

“I’m thrilled to be at Aperio, a company that closely aligns with my own values and commitments to quality, transparency and customer-centricity. I believe that relationships and trust are the foundation for biotechs and CROs to work together successfully,” says Ross. “I am excited to leverage my deep industry experience and vast network with the biotech industry to drive strategic growth for Aperio in oncology, CNS and other therapeutic areas.”

View source on: shorturl.at/pBNUZ

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable Clinical Development services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com

Aperio Clinical Outcomes Contact:
Heather Newbold: +1 919-604-5704
heather.newbold@aperioclinical.com


PharmaVoice Features Cari Kniola on Market Growth Factors and Barriers in Decentralized Clinical Trials

decentralized clinical trials

PharmaVoice Features Cari Kniola on Market Growth Factors and Barriers in Decentralized Clinical Trials

OCTOBER 5, 2021

Decentralized Clinical Trials may be one of the hottest buzzwords in clinical research right now, but Decentralized Clinical Trials are not new. In fact, technologies that support aspects of remote trials – such as wearables, eCOA, eConsent and Electronic health Records -have been around for awhile.

According to PharmaVoice’s recent Pulse Report on Decentralized Clinical Trials, “what is transformational is the combination of multiple technologies to seamlessly knit together a better patient journey. “

With the market set to explode to more than $1.63 billion by 2027, read what Aperio’s Director of Corporate Strategy Cari Kniola and other industry thought leaders had to say about market growth factors and barriers to overcome in Decentralized Clinical Trials in PharmaVoice’s October issue of the Pulse Report. Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Aperio's Stacey King and Mike Ferree Talk Risk Based Quality Management at SCDM 2021

Aperio's Stacey King and Mike Ferree Talk Risk Based Quality Management at SCDM 2021

SEPTEMBER 15, 2021

Aperio’s Stacey King will facilitate an On Demand session for Society for Clinical Data Management 2021 titled “Risk Based Quality Management – Every Piece of the Puzzle Matters.”

During the session, Stacey and her esteemed panelists will discuss the different components of RBQM; the roles and responsibilities of RBQM and Centralized Monitoring Analytics; why it’s critical to implement a QbD approach to study design; and how the field of Clinical Data Management is evolving.

Stacey will be joined by a panel of industry experts, including Aperio’s Micheal Ferree, Medidata’s Brian Barnes, Pfizer’s Crupa K., and CMED’s Rachel Oakley.

The On Demand session is available on the Society for Clinical Data Management (SCDM) 2021 website Sept. 19th -29th. You can access the session here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Aperio Joins Florence Healthcare on Live Webinar Panel “Moving Beyond COVID"

hybrid and virtual trials

Aperio Joins Florence Healthcare on Live Webinar Panel “Moving Beyond COVID"

MAY 13, 2021

Aperio’s Suzanne Kincaid recently participated as a panelist in Florence Healthcare’s Expert Webinar Series “Moving Beyond COVID: Lessons Learned by Sponsors and CROs.” Suzanne was joined on the panel by fellow industry experts from Pfizer and Total Clinical Trial Management.

During the webinar, panelists discussed:

  • What changes they made in response to COVID disruptions to their operations
  • How they are using Florence eHub to connect to study sites with an eISF/eBinders
  • How they helped sites navigate the rapid transition
  • Where they are looking to evolve in the next 3-5 years

Miss the webinar or want to view it again? Watch here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Suzanne Kincaid to Present on Managing Risk in Clinical Research at MAGI's Spring Conference

hybrid and virtual trials

Suzanne Kincaid to Present on Managing Risk in Clinical Research at MAGI's Spring 2021 Clinical Research Conference

APRIL 22, 2021

Join Aperio’s Suzanne Kincaid as she presents on a panel titled “Risky Business: Assessing, Characterizing & Managing Risk in Clinical Research” at MAGI’s Spring 2021 Clinical Research Conference.

The panel, facilitated by Dawn Niccum with inSeption Group, will discuss the foundations of risk management in clinical research; identify critical processes and data as a basis for risk identification; and review risk management tools, including dashboards and data analytics. Fellow industry experts – Maryse Brulotte with University of Utah and Katelyn Penney with St. Luke’s Health System – will join Dawn and Suzanne for the panel.

The panel takes place on Wednesday, April 28, 2021 from 11:00 AM EDT – 1:30 PM EDT.

Register to attend MAGI.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


PharmaVoice Sits Down with Aperio's Suzanne Kincaid to Discuss Top Priorities in Clinical Research for 2021

hybrid and virtual trials

PharmaVoice Sits Down with Aperio's Suzanne Kincaid to Discuss Top Priorities in Clinical Research for 2021

APRIL 8, 2021

Check out PharmaVOICE‘s April 2021 “Trend Tracking” article and discover what Aperio’s Suzanne Kincaid and other PharmaVOICE 100 leaders had to say about their top priorities in clinical research for 2021 and leadership skills that got them through the pandemic.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Cari Kniola Says Decentralized Clinical Trials Is the Next Big Game Changer

decentralized clinical trials

Cari Kniola Says Decentralized Clinical Trials Is the Next Big Game Changer

MARCH 1, 2021

Check out PharmaVOICE‘s 20th Anniversary edition and hear what Aperio’s Director of Corporate Strategy Cari Kniola has to say about the revolutionary role that data analytics has played in the clinical research industry and how patient-centric healthcare technologies and decentralized trials are the next big game changers.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Faye Woolf Talks to PharmaVoice about COVID-19's Positive Impact on the Clinical Trial Industry

COVID-19 Positive Impact on Clinical Trials

Faye Woolf Talks to PharmaVoice about the Positive Impact of COVID-19 on the Clinical Trial Industry

FEBRUARY 2, 2021

Check-out PharmaVoice’s February edition of Commanders & Chiefs to see what Aperio’s Founder and CEO Faye Woolf had to say about getting back to the business of clinical trials and how COVID-19 forced the industry to adapt and adopt some much needed changes.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry's Shift to Hybrid and Virtual Trials

PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry's Shift to Hybrid and Virtual Trials

SEPTEMBER 10, 2020

Suzanne Kincaid – 2020 PharmaVOICE 100 winner – speaks with PharmaVOICE Editor Taren Grom about her passion for mentoring the next generation of clinical research professionals and her thoughts on the clinical research industry’s rapid shift towards hybrid and virtual trials.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com